Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Terminated 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 7Gastrointestinal 3Dermatologic 3Sarcoma 2Genitourinary 2Breast 2Tumor-Agnostic 1Plasma cell 1

Conditions

Pancreatic Neoplasms 2Chemotherapy;Advanced Gastric Cancer;Cisplatin;Disulfiram 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Disulfiram × Gastrointestinal × Clear all
NCT02671890 2025-01-07

Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer

Mayo Clinic

Phase 1 Terminated
16 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03714555 2023-10-18

Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine

HonorHealth Research Institute

Phase 2 Terminated
1 enrolled 7 charts
Gastrointestinal

Pancreatic Neoplasms

NCT05667415 2022-12-28

Treatment of Advance Gastric Cancer With Disulfiram

First People's Hospital of Hangzhou

Phase NA Not yet recruiting
40 enrolled
Gastrointestinal

Chemotherapy;Advanced Gastric Cancer;Cisplatin;Disulfiram

Data powered by HemOnc (CC BY 4.0) Colophon ⚡